Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection

American Journal of Transplantation

Volumn 17, Issue 2, 2017, Pages 496-505

  Afzali, B ^a,b   Chapman, E ^a   Racape M ^c   Adam, B ^a   Bruneval, P ^c   Gil, F ^a   Kim, D ^a   Hidalgo, L ^a   Campbell, P ^a   Sis, B ^a   Duong Van Huyen, J P ^c   Mengel, M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

biopsy; clinical research practice; heart transplantation cardiology; molecular biology; pathology histopathology; rejection: antibody mediated (ABMR)

Indexed keywords

FORMALDEHYDE; HLA ANTIBODY; PARAFFIN; ALLOANTIBODY; BIOLOGICAL MARKER;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ANTIBODY MEDIATED REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; GENE EXPRESSION; GRAFT SURVIVAL; HEART GRAFT; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INFLAMMATION; INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION CRITERIA; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MIDDLE AGED; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; NATURAL KILLER CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROLOGY; TRANSMISSION ELECTRON MICROSCOPY; VALIDATION STUDY; BIOPSY; CHEMISTRY; DONOR; FOLLOW UP; GENE EXPRESSION PROFILING; GENETICS; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; IMMUNOLOGY; METABOLISM; RISK FACTOR;

ADULT; ALLOGRAFTS; BIOMARKERS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; FORMALDEHYDE; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; ISOANTIBODIES; KILLER CELLS, NATURAL; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS;

EID: 84980371732     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13956     Document Type: Article

References (40)

1. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-First Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation. J Heart Lung Transplant 2014; 33: 996–1008.
2. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30: 252–269.
3. Zhang Q, Cecka JM, Gjertson DW, et al. HLA and MICA: Targets of antibody-mediated rejection in heart transplantation. Transplantation 2011; 91: 1153–1158.
4. Reinsmoen NL, Lai C-H, Mirocha J, et al. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome. Transplantation 2014; 97: 595–601.
5. Kfoury AG, Hammond MEH, Snow GL, et al. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant 2009; 28: 781–784.
6. Wu GW, Kobashigawa JA, Fishbein MC, et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28: 417–422.
7. Berry GJ, Burke MM, Andersen C, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2013; 32: 1147–1162.
8. Mengel M, Husain S, Hidalgo L, Sis B. Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int 2012; 25: 611–622.
9. Farkash EA, Colvin RB. Diagnostic challenges in chronic antibody-mediated rejection. Nat Rev Nephrol 2012; 8: 255–257.
10. Kobashigawa JA. Continuing the pursuit of heart transplant antibody-mediated rejection. J Heart Lung Transplant 2015; 34: 1134–1135.
11. Mengel M, Campbell P, Gebel H, et al. Precision diagnostics in transplantation: From bench to bedside. Am J Transplant 2013; 13: 562–568.
12. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 Working Formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710–1720.
13. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12: 1168–1179.
14. Tible M, Loupy A, Vernerey D, et al. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation. J Heart Lung Transplant 2013; 32: 769–776.
15. Loupy A, Cazes A, Guillemain R, et al. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant 2011; 11: 1478–1487.
16. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312–2323.
17. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010; 10: 1812–1822.
18. Akiyoshi T, Hirohashi T, Alessandrini A, et al. Role of complement and NK cells in antibody mediated rejection. Hum Immunol 2012; 73: 1226–1232.
19. Lepin EJ, Zhang Q, Zhang X, et al. Phosphorylated S6 ribosomal protein: A novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant 2006; 6: 1560–1571.
20. Reeve J, Einecke G, Mengel M, et al. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009; 9: 1802–1810.
21. Dean PG, Park WD, Cornell LD, Gloor JM, Stegall MD. Intragraft gene expression in positive crossmatch kidney allografts: Ongoing inflammation mediates chronic antibody-mediated injury. Am J Transplant 2012; 12: 1551–1563.
22. Halloran PF, De Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215–2222.
23. Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 2012; 12: 1180–1191.
24. Mengel M, Sis B, Kim D, et al. The molecular phenotype of heart transplant biopsies: Relationship to histopathological and clinical variables. Am J Transplant 2010; 10: 2105–2115.
25. Reeve J, Sellarés J, Mengel M, et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 2013; 13: 645–655.
26. Sellarés J, Reeve J, Loupy A, et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 2013; 13: 971–983.
27. Geiss GK, Bumgarner RE, Birditt B, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26: 317–325.
28. Reis PP, Waldron L, Goswami RS, et al. mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol 2011; 11: 46.
29. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32–35.
30. Park WD, Grande JP, Ninova D, et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952–960.
31. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006; 6: 150–160.
32. Fedrigo M, Leone O, Burke MM, et al. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): A multicenter pilot study from the AECVP. Am J Transplant 2015; 15: 526–534.
33. Holweg CTJ, Potena L, Luikart H, et al. Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation 2011; 123: 2236–2243.
34. Kfoury AG, Miller DV, Snow GL, et al. Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. J Heart Lung Transplant 2016; 35: 335–341.
35. Gupta G, Abu Jawdeh BG, Racusen LC, et al. Late antibody-mediated rejection in renal allografts: Outcome after conventional and novel therapies. Transplantation 2014; 97: 1240–1246.
36. Loupy A, Toquet C, Rouvier P, et al. Late failing heart allografts: Pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection. Am J Transplant 2016; 16: 111–120.
37. Adam B, Afzali B, Dominy KM, et al. Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue. Clin Transplant 2016; 30: 295–305.
38. Mengel M, Chan S, Climenhaga J, et al. Banff initiative for quality assurance in transplantation (BIFQUIT): Reproducibility of C4d immunohistochemistry in kidney allografts. Am J Transplant 2013; 13: 1235–1245.
39. Szymańska S, Grajkowska W, Sobieszczańska-Małek M, Zieliński T, Pronicki M. Reclassification of C4d-positive endomyocardial biopsy (EMB) according to new International Society for Heart and Lung Transplantation (ISHLT) 2013 categories for reporting pathologic antibody-mediated rejection (pAMR): Preliminary data from a Polish sing. Ann Transplant 2015; 20: 351–356.
40. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med 2012; 366: 489–491.